PIM
GBT

Partner Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Partner Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-946
Closed -$46K – 123
2018
Q1 		$46K Buy
+946
New +$52.8K 0.05% 84
2016
Q3 		– Sell
-20,383
Closed -$338K – 108
2016
Q2 		$338K Buy
20,383
+3,535
+21% +$71.3K 0.55% 56
2016
Q1 		$267K Buy
16,848
+1,214
+8% +$21.6K 0.43% 57
2015
Q4 		$505K Sell
15,634
-2,258
-13% -$97.8K 0.83% 41
2015
Q3 		$754K Buy
+17,892
New +$844K 1.14% 30

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Partner Investment Management's GBT Position: Q2 2018 in Review

Partner Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2018, closing a stake of 946 shares — an estimated $46K sold.

Partner Investment Management first reported a position in GBT in Q3 2015 and held it in 5 quarters. The position peaked at $754K in Q3 2015. 196 funds tracked by Wall St. Rank hold GBT as of Q2 2018.

  • Partner Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Partner Investment Management sold 946 Global Blood Therapeutics, Inc. shares in Q2 2018, an estimated $46K.
  • Partner Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 5 quarters.
  • Partner Investment Management's Global Blood Therapeutics, Inc. position peaked at $754K in Q3 2015.
  • 196 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2018.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.